Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2008: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Research Abstract |
Recent studies have indicated the utility of mineralocorticoid receptor antagonist in cardiovascular injuries. Actually, chronic treatment with aldosterone can induce several pathological features, including cardiac hypertrophy, in experimental animals. In this study, we showed that NCX1 would be implicated in the progression of aldosterone-induced cardiac remodeling in experimental model of hyper-aldosteronism. These results suggest that NCX1 inhibitors might be useful for heart failure therapeutically.
|